New and Generic Drug Approvals
July 7, 2011
Amlodipine Besylate and Benazepril Hydrochloride Capsules, TEVA
Pharmaceuticals, Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Lupin Ltd., Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Mylan
Pharmaceuticals, Inc., Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Watson
Laboratories Inc., Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Dr. Reddy's
Laboratories Ltd., Approval
Coreg (carvedilol) Tablets, SmithKline Beecham, Labeling Revision
Coreg CR (carvedilol phosphate) Extended Release Capsules, SmithKline
Beecham, Labeling Revision
Duloxetine Hydrochloride Delayed Release Capsules, Wockhardt Ltd.,
Tentative Approval
Felbatol (felbamate) Tablets and Oral Suspension, Meda Pharmaceuticals
Inc., Labeling Revision
Kemadrin (procyclidine hydrochloride) Tablets, Monarch
Pharmaceuticals, Inc., Labeling Revision
Micardis (telmisartan) Tablets, Boehringer Ingelheim Pharmaceuticals,
Inc, Labeling Revision
Vancomycin Hydrochloride Injection, Pfizer Inc., Approval
Xenazine (tetrabenazine) Tablets, Valeant Pharmaceutical, Labeling Revision
Comentarios
Publicar un comentario